Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zadicose
- Development stage
- Unknown
- Lead developer
- Zafa
- Administration
- Oral
01
Overview
Zadicose is a medicinal lozenge developed and marketed by Zafa Pharmaceutical in Pakistan for the symptomatic relief of sore throats and minor mouth pain. The primary active ingredient is an extract of *Morus nigra* (Black Mulberry), which is traditionally recognized for its astringent, anti-inflammatory, and soothing properties on the respiratory and oral mucosa. The lozenges are designed to dissolve slowly in the oral cavity, providing localized and fast-acting relief from irritation caused by infections or environmental pollutants. It is positioned as a natural alternative for managing throat discomfort.
- Brand names
- ZadicoseZadicose-Zafa
- Other names
- Zadicose Lozenges
Beyond the preview
Go deeper on Zadicose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zadicose.